Tislelizumab Approved for First-Line in ESCC ...Middle East

Medscape - News
Tislelizumab Approved for First-Line in ESCC
The Chinese immune checkpoint inhibitor has picked up its third indication within a year. Medscape Medical News

Hence then, the article about tislelizumab approved for first line in escc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tislelizumab Approved for First-Line in ESCC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News